CVS Health报告Q2收入丰厚,尽管有诉讼费,2025年的预测却提高了。 CVS Health reported strong Q2 earnings, raising 2025 forecast despite litigation charges.

CVS Health报告第二季度收入强劲,预测收入为989亿美元。 CVS Health reported strong second-quarter earnings, with revenue at $98.9 billion, beating predictions. 经调整后的收入最高分析师预测为每股1.81美元。 Adjusted earnings topped analyst forecasts at $1.81 per share. 该公司将2025年的收入预测提高到每股6.30至6.40美元,反映了药店和保险部门的增长。 The company raised its 2025 earnings forecast to $6.30 to $6.40 per share, reflecting growth in its pharmacy and insurance segments. 尽管由于诉讼费用导致营业收入下降,但CVS的股票在积极的业绩后急剧上. Despite a decline in operating income due to litigation charges, CVS's stock surged in response to the positive results.